Companies

Transaction Transforms Wright Medical into High Growth Extremities and Biologics Pure Play and Expands Growth Opportunities for OrthoRecon Business
Purchase Price of $290 Million Cash

Medtronic, Inc.  today issued a press release in which it acknowledged the publication of the findings from Yale University’s third-party, … continue reading “INFUSE® Bone Graft Review Leaves Questions”

Covidien has announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its … continue reading “Pivotal Study Results For Covidien’s Pipeline™ Embolization Device”

Codman Neuro has announced the gaining of CE mark approval for its self-expanding clot removal device. The Revive SE nitinol basket for removal of clots in the treatment of ischemic stroke features newly enhanced navigation which should speed up restoration of blood flow.

J&J Company, Cordis Corporation has received FDA clearance of its latest innovation in guiding catheters: the ADROIT™ 6F Guiding Catheter, which the company says means easier advancement of devices, with its 0.072′ diameter, the largest inner diameter of any guiding catheter in the U.S. .

Medtronic, Inc. has announced the CE Mark and the European launch of its ReDuX™ Plier, a new instrument specially designed … continue reading “Newly CE Marked Medtronic ReDuX™ Plier Facilitates Osteotomies in Spinal Deformity Surgeries”

Following the announcement that it is to buy Israeli microlaparoscopy business Eon Surgical, Teleflex has now snapped up the assets of airway management device innovator Ultimate Medical.

Last month St. Jude Medical, Inc. told us it had gained CE mark approval for its next-generation Ellipse™ and SJM … continue reading “FDA Approval For St. Jude’s Ellipse™ and Assura™ ICD/CRT-Ds”

Abbott is commencing a trial to study its innovative “Dissolving” Heart stent compared to its own drug-eluting stents in patients with Coronary Artery Disease.

St. Jude Medical, Inc. has made a $40 million equity investment in Spinal Modulation, Inc., a company that has developed … continue reading “St. Jude’s “Try Before You Buy” Deal With Spinal Modulation, Inc.”

Device company Teleflex Inc. is to acquire Israeli company Eon Surgical, Ltd. in a deal, the terms of which have … continue reading “Teleflex Hopes Eon Surgical Acquisition Will Help It Accelerate Microlaparoscopy Adoption”

Data from two European studies of Abbott’s MitraClip® therapy for the treatment of mitral regurgitation demonstrated low rates of hospital mortality and adverse events and significant improvements in day-to-day quality of life at one year following treatment

Cook Medical has received  FDA 510(k) clearance for its Evolution® Biliary Controlled-Release Uncovered Stent. The company says its device is the … continue reading “FDA Clears Cook’s Evolution® Biliary Controlled-Release Uncovered Stent”

St. Jude Medical, Inc. has gained U.S. FDA approval to begin the EnligHTN IV Renal Denervation Study, the first U.S. trial using the EnligHTN™ Multi-Electrode Renal Denervation System to treat patients with drug-resistant high blood pressure.

Zimmer Holdings, Inc. has acquired NORMED Medizin-Technik GmbH, of Tuttlingen, Germany-based a provider of innovative technologies for the foot and ankle, hand and wrist reconstruction and trauma markets. NORMED’s range extends to specialized plates, screws and instruments, including systems for bone reconstruction and fracture repair, fusion procedures and external fixation.

Medtronic, Inc. is trumpeting with new data on its Endurant AAA stent graft, which it says demonstrates durable clinical performance through three years of patient follow-up in the endovascular repair of Abdominal Aortic Aneurysms.